Highline Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1K | Buy |
43
+1
| +2% | +$445 | 0.01% | 230 |
|
|
2025
Q1 | $20.4K | Buy |
42
+26
| +163% | +$12.6K | 0.01% | 203 |
|
|
2024
Q4 | $6.44K | Sell |
16
-43
| -73% | -$17.3K | ﹤0.01% | 299 |
|
|
2024
Q3 | $27.4K | Buy |
59
+48
| +436% | +$22.3K | 0.01% | 162 |
|
|
2024
Q2 | $5.16K | Buy |
11
+1
| +10% | +$469 | ﹤0.01% | 289 |
|
|
2024
Q1 | $4.18K | Hold |
10
| – | – | ﹤0.01% | 285 |
|
|
2023
Q4 | $4.07K | Hold |
10
| – | – | ﹤0.01% | 256 |
|
|
2023
Q3 | $3.48K | Hold |
10
| – | – | ﹤0.01% | 243 |
|
|
2023
Q2 | $3.52K | Hold |
10
| – | – | ﹤0.01% | 194 |
|
|
2023
Q1 | $3.15K | Hold |
10
| – | – | ﹤0.01% | 204 |
|
|
2022
Q4 | $2.89K | Hold |
10
| – | – | ﹤0.01% | 198 |
|
|
2022
Q3 | $2.9K | Buy |
+10
| New | +$2.9K | ﹤0.01% | 191 |
|